Peptide TherapeuticsPeer Reviewed

Efficacy and Safety of Telitacicept and Mycophenolate Mofetil in the Treatment of Neuromyelitis Optica Spectrum Disorders.

Authors (7)
Shaomin ZuoDepartment of Neurology, People's Hospital of Henan University, Zhengzhou, Henan Province, China.
Wenning YangDepartment of Neurology, People's Hospital of Henan University, Zhengzhou, Henan Province, China.
Xiaojuan WangDepartment of Neurology, People's Hospital of Henan Provincial, Zhengzhou, Henan Province, China.
Milan ZhangDepartment of Neurology, People's Hospital of Henan Provincial, Zhengzhou, Henan Province, China.
Annals of Indian Academy of Neurology
Unknown
Published
Oct 13, 2025
View Original

Abstract

Abstract not available - data parsing issue resolved

Keywords

Neuromyelitis optica spectrum disordermycophenolate mofetiltelitacicept

Article Metrics

Sourcepubmed

Related Research

Explore more articles in this research category to discover related studies and findings.

View more in Peptide Therapeutics